1. Home
  2. MGTX

as 08-01-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Founded: 2015 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 622.0M IPO Year: N/A
Target Price: $24.00 AVG Volume (30 days): 673.2K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.27 EPS Growth: N/A
52 Week Low/High: $3.85 - $8.98 Next Earning Date: 08-11-2025
Revenue: $34,508,000 Revenue Growth: 203.23%
Revenue Growth (this year): 228.65% Revenue Growth (next year): 145.06%

MGTX Daily Stock ML Predictions

Share on Social Networks: